{"id":"https://openalex.org/W2046863780","doi":"https://doi.org/10.2174/1381612053381792","title":"Novel Integrin Antagonists Derived from Thrombospondins","display_name":"Novel Integrin Antagonists Derived from Thrombospondins","publication_year":2005,"publication_date":"2005-03-01","ids":{"openalex":"https://openalex.org/W2046863780","doi":"https://doi.org/10.2174/1381612053381792","mag":"2046863780","pmid":"https://pubmed.ncbi.nlm.nih.gov/15777239"},"language":"en","primary_location":{"id":"doi:10.2174/1381612053381792","doi":"https://doi.org/10.2174/1381612053381792","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612053381792","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047294334","display_name":"Mar\u00eda Jos\u00e9 Calzada","orcid":"https://orcid.org/0000-0001-8615-960X","observed_orcids":["https://orcid.org/0000-0001-8615-960X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Calzada","raw_affiliation_strings":["Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031078822","display_name":"David D. Roberts","orcid":"https://orcid.org/0000-0002-2481-2981","observed_orcids":["https://orcid.org/0000-0002-2481-2981"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Roberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9912,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.88969072,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"11","issue":"7","first_page":"849","last_page":"866"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/integrin-antagonists","display_name":"integrin antagonists","score":0.9919999837875366},{"id":"https://openalex.org/keywords/thrombospondin-1","display_name":"thrombospondin-1","score":0.8930000066757202},{"id":"https://openalex.org/keywords/thbs2","display_name":"thrombospondin-2","score":1.0},{"id":"https://openalex.org/keywords/integrin-alpha3beta1","display_name":"alpha3beta1 integrin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/integrin-alpha6beta1","display_name":"alpha6beta1 integrin","score":0.996999979019165},{"id":"https://openalex.org/keywords/integrin-alpha4beta1","display_name":"alpha4beta1 integrin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pathological-angiogenesis","display_name":"pathological angiogenesis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/integrin-inhibitors","display_name":"integrin inhibitors","score":0.6899999976158142},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.9309999942779541},{"id":"https://openalex.org/keywords/inflammatory-diseases","display_name":"inflammatory diseases","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.9005361795425415},{"id":"https://openalex.org/C2910422434","wikidata":"https://www.wikidata.org/wiki/Q419341","display_name":"Thrombospondins","level":5,"score":0.810979962348938},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.682295560836792},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5264687538146973},{"id":"https://openalex.org/C99194444","wikidata":"https://www.wikidata.org/wiki/Q14906367","display_name":"Thrombospondin 1","level":3,"score":0.47492581605911255},{"id":"https://openalex.org/C167814343","wikidata":"https://www.wikidata.org/wiki/Q419341","display_name":"Thrombospondin","level":4,"score":0.4413684904575348},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3394005000591278},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33103126287460327},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3281094431877136},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2994183897972107},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28161218762397766},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18004369735717773},{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.0},{"id":"https://openalex.org/C55728118","wikidata":"https://www.wikidata.org/wiki/Q425402","display_name":"Metalloproteinase","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016023","descriptor_name":"Integrins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018919","descriptor_name":"Neovascularization, Physiologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018919","descriptor_name":"Neovascularization, Physiologic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018955","descriptor_name":"CD36 Antigens","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019699","descriptor_name":"Thrombospondins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019699","descriptor_name":"Thrombospondins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019699","descriptor_name":"Thrombospondins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612053381792","doi":"https://doi.org/10.2174/1381612053381792","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612053381792","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:15777239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15777239","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2138743502","https://openalex.org/W1983811312","https://openalex.org/W2103386895","https://openalex.org/W1975799575","https://openalex.org/W126703147","https://openalex.org/W2163829418","https://openalex.org/W147592962","https://openalex.org/W1966022051","https://openalex.org/W2116063661","https://openalex.org/W126281322"],"abstract_inverted_index":{"Specific":[0],"antagonists":[1,156],"have":[2,12,32,79,100],"been":[3,13,81],"successfully":[4],"developed":[5],"for":[6,67,76,104,155],"several":[7],"different":[8],"integrins.":[9],"Clinical":[10],"trials":[11],"initiated":[14],"to":[15,30,163],"study":[16],"therapeutic":[17],"uses":[18],"of":[19,87,93,143,157,161],"these":[20,77,158],"inhibitors":[21],"in":[22,127,150],"cancer,":[23],"thrombosis,":[24],"and":[25,41,57,95,106,129,145,152,160,167],"inflammatory":[26],"diseases.":[27,169],"Most":[28],"efforts":[29],"date":[31],"focused":[33],"on":[34],"the":[35,42,47,116,141],"platelet":[36],"integrin":[37,44,48],"alphaIIbbeta3,":[38],"endothelial":[39],"alphavbeta3,":[40],"leukocyte":[43],"alpha4beta1.":[45],"However,":[46],"family":[49],"contains":[50],"additional":[51],"members":[52],"with":[53],"interesting":[54],"tissue":[55],"specificities":[56,142],"functional":[58],"properties":[59],"that":[60],"could":[61],"also":[62],"be":[63],"useful":[64],"molecular":[65],"targets":[66],"disease":[68],"intervention.":[69],"In":[70],"many":[71],"cases,":[72],"specific":[73,88],"recognition":[74,97],"motifs":[75,103,113],"integrins":[78,99,108,123,159],"not":[80],"identified,":[82],"which":[83],"has":[84],"precluded":[85],"development":[86],"antagonists.":[89],"Our":[90],"recent":[91,138],"studies":[92],"thrombospondin-1":[94],"thrombospondin-2":[96],"by":[98,115,132],"revealed":[101],"novel":[102],"alpha3beta1":[105,144],"alpha6beta1":[107,146],"as":[109,111],"well":[110,117],"new":[112],"recognized":[114],"studied":[118],"alpha4beta1":[119,162],"integrin.":[120],"These":[121],"three":[122],"play":[124],"distinct":[125],"roles":[126],"angiogenesis":[128,166],"its":[130],"modulation":[131],"thrombospondins.":[133],"This":[134],"review":[135],"will":[136],"discuss":[137],"insights":[139],"into":[140],"integrins,":[147],"their":[148],"functions":[149],"angiogenesis,":[151],"potential":[153],"applications":[154],"control":[164],"pathological":[165],"other":[168]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}